Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients
- PMID: 34355394
- DOI: 10.1111/bjh.17748
Safety and efficacy of a Hb-triggered single-unit red cell transfusion policy for haemato-oncological inpatients
References
-
- Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirement in critical care. N Engl J Med. 1999;340(6):409-17.
-
- Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2016;10:CD002042.
-
- Carson JL, Stanworth SJ, Alexander JH, Roubinian N, Fergusson DA, Triulzi DJ, et al. Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease. Am Heart J. 2018;200:96-101.
-
- Hoeg RT, Leinoe EB, Andersen P, Klausen TW, Birgens HS. Measuring the impact of a restrictive transfusion guideline in patients with acute myeloid leukaemia. Vox Sang. 2013;105(1):81-4.
-
- Webert KE, Cook RJ, Couban S, Carruthers J, Lee KA, Blajchman MA, et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 2008;48(1):81-91.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical